肝细胞癌干预治疗后的MRI:随着时间的推移,典型的变化
Jens Kübler1, Antonia Ashkar1, Moritz T Winkelmann1
1Department of Diagnostic and Interventional Radiology, Universitätsklinikum Tübingen, Tuebingen, Germany.
概括
磁共振成像 (MRI) 在干预治疗后监测肝细胞癌 (HCC) 是至关重要的. 了解治疗特异性的变化,并使用像mRECIST这样的标准化系统,可以确保对治疗反应的准确评估和早期复发检测.
科学领域:
- 放射学 放射学是一门学科.
- 在瘤学瘤学.
- 干预性放射学 干预性放射学
背景情况:
- 肝细胞癌 (HCC) 管理涉及多种干预疗法,包括跨动脉化学栓塞 (TACE),热废除 (RFA,MWA),选择性内部放射治疗 (SIRT) 和立体体辐射疗法 (SBRT).
- 用磁共振成像 (MRI) 进行治疗后监测对于检测复发至关重要,需要深入了解治疗诱导的成像变化.
研究的目的:
- 审查和巩固对HCC各种干预疗法的典型MRI发现的知识.
- 强调标准化评估系统对于评估治疗反应和指导患者管理的重要性.
主要方法:
- 一个结构化的PubMed文献搜索 (2000-2025年) 使用关键词与HCC,MRI和特定的干预技术相关.
- 包括当前的指导方针和机构临床经验,以提供全面的概述.
主要成果:
- 干预后的MRI发现是取决于程序的,TACE和热废除后立即发生变化,SIRT和SBRT后延迟发生变化.
- 标准化分类系统 (mRECIST,EASL,LI-RADS-TR) 对于结构化和可重复的治疗反应评估至关重要.
- 准确的解释需要区分残留瘤,复发和治疗引起的变化,考虑到时间模式和潜在的组合治疗效应.
结论:
- 在MRI解释和标准化评估系统方面的专业知识对于接受干预治疗的HCC患者的有效随访至关重要.
- 本综述提供了一个以实践为导向的综合现有证据,用于MRI随访成像在HCC.
- 系统疗法被排除在外,限制了对组合治疗场景的概括性.
相关概念视频
Magnetic Resonance Imaging
9.0K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
9.0K
Imaging Studies IV: Magnetic Resonance Imaging
216
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
216


